Reckitt gives weak scrub to valuation stain
The author is a Reuters Breakingviews columnist. The opinions expressed are her own.
By Karen Kwok
LONDON, July 24 (Reuters Breakingviews) -Reckitt Benckiser RKT.L CEO Kris Licht is giving his firm’s valuation stain a gentle scrub. The 31 billion pound Durex maker is selling some of its home cleaning brands and may exit its baby milk division, which is facing legal woes in the United States. The problem is it’s unclear when Reckitt can sell them, and when investors can leave the infant formula litigation problems behind.
Reckitt has had a rocky year so far. Shareholders have wiped 5 billion pounds off its market value since March, when an Illinois court awarded $60 million in damages to a mother whose child died after consuming Mead Johnson formula milk. The worries are there are more legal hits to come, potentially reaching 2 billion pounds, Bernstein estimates. Inflation is also making it harder for Reckitt to pass on costs to consumers, damaging sales growth. The London-listed group’s shares have fallen 18% so far this year.
As a result Licht is cleaning house. He will sell slow-growing hygiene brands like mould remover Cillit Bang, and is pledging to get out of the nutrition business, which mostly comprises the baby milk maker Mead Johnson. That should highlight the hidden value in Reckitt.
Assume the hygiene castoffs fetch 2.5 times 2023 sales, as per Jefferies estimates, or 4.8 billion pounds. Next, put the rest of the hygiene business on a richer 4.8 times revenue multiple, in line with peers Procter & Gamble PG.N and Church & Dwight CHD.N, and it’s worth 20 billion pounds. Finally, the health unit, which makes Durex condoms, could be valued at 24 billion pounds using a 4 times sales multiple, the average of Haleon HLN.L and Johnson & Johnson JNJ.N. Add it up, and Reckitt might be worth 49 billion pounds including net debt, some 29% above its current enterprise value, even before factoring in the troubled baby milk division.
Yet investors don’t seem convinced. Reckitt shares barely moved on Wednesday morning after the breakup was announced. The lack of clarity on timing is one issue. So far, Licht has not yet given a date for when the baby unit will be sold, raising the risk of higher than expected losses as cases come to trial next year. And the home care assets won’t be sold until the end of next year, and Reckitt hasn’t said whether it will return the money to shareholders or invest in the business. Licht’s fix for Reckitt goes in the right direction, but needs an extra polish.
Follow @karenkkwok on X
CONTEXT NEWS
British consumer goods group Reckitt Benckiser on July 24 said it would sell its home care brands, which include Air Wick and Cillit Bang, and said it was looking at all strategic options for Mead Johnson, which has recently faced litigation in the United States over an infant formula product.
Reckitt acquired U.S. baby formula maker Mead Johnson Nutrition for $16.6 billion in 2017, but is currently seeking to overturn a $60 million verdict in a lawsuit after a jury ordered the unit to pay the mother of a premature baby who died after being fed the Enfamil baby formula.
The British consumer goods company also lowered its full-year sales growth forecast for 2024 to 1%-3%, down from its previous forecast of a 2%-4% rise. Reckitt said it would launch a share buyback of up to 1 billion pounds and increase its interim dividend.
Reckitt shares rose 0.29% at 0907 GMT on July 24.
Editing by Neil Unmack and Oliver Taslic
면책조항: XM Group 회사는 체결 전용 서비스와 온라인 거래 플랫폼에 대한 접근을 제공하여, 개인이 웹사이트에서 또는 웹사이트를 통해 이용 가능한 콘텐츠를 보거나 사용할 수 있도록 허용합니다. 이에 대해 변경하거나 확장할 의도는 없습니다. 이러한 접근 및 사용에는 다음 사항이 항상 적용됩니다: (i) 이용 약관, (ii) 위험 경고, (iii) 완전 면책조항. 따라서, 이러한 콘텐츠는 일반적인 정보에 불과합니다. 특히, 온라인 거래 플랫폼의 콘텐츠는 금융 시장에서의 거래에 대한 권유나 제안이 아닙니다. 금융 시장에서의 거래는 자본에 상당한 위험을 수반합니다.
온라인 거래 플랫폼에 공개된 모든 자료는 교육/정보 목적으로만 제공되며, 금융, 투자세 또는 거래 조언 및 권고, 거래 가격 기록, 금융 상품 또는 원치 않는 금융 프로모션의 거래 제안 또는 권유를 포함하지 않으며, 포함해서도 안됩니다.
이 웹사이트에 포함된 모든 의견, 뉴스, 리서치, 분석, 가격, 기타 정보 또는 제3자 사이트에 대한 링크와 같이 XM이 준비하는 콘텐츠 뿐만 아니라, 제3자 콘텐츠는 일반 시장 논평으로서 "현재" 기준으로 제공되며, 투자 조언으로 여겨지지 않습니다. 모든 콘텐츠가 투자 리서치로 해석되는 경우, 투자 리서치의 독립성을 촉진하기 위해 고안된 법적 요건에 따라 콘텐츠가 의도되지 않았으며, 준비되지 않았다는 점을 인지하고 동의해야 합니다. 따라서, 관련 법률 및 규정에 따른 마케팅 커뮤니케이션이라고 간주됩니다. 여기에서 접근할 수 있는 앞서 언급한 정보에 대한 비독립 투자 리서치 및 위험 경고 알림을 읽고, 이해하시기 바랍니다.
